Early stent thrombosis after superficial femoral artery stenting successfully treated with transcatheter rheolytic thrombectomy in a patient with reduced aspirin responsiveness  by Trabattoni, Daniela et al.
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Purpose:  To  describe  a case  of early  superﬁcial  femoral  artery  (SFA)  thrombosis  after  stenting  in an  aspirin
low-responsive  patient  successfully  treated  with  percutaneous  mechanical  thrombectomy.
Clinical and  interventional  summary:  Early  SFA  stent  thrombosis  occurred  in  a 65-year-old  man  treated
with  multiple  stent  implantation  for  chronic  total occlusion  of  the  left SFA.  The  potential  cause  for  throm-
bosis  was  a  suboptimal  PTA  [percutaneous  transluminal  angioplasty]  result  characterized  by  no-ﬂow
limiting  residual  linear  dissection  left untreated  and  which  was  associated  with low  responsiveness  to
aspirin.  Rapid  thrombus  removal  and  ﬂow  restoration  were  obtained  with  the Angiojet Ultra  Thrombec-
tomy  System  (Medrad,  Warrendale,  PA,  USA).
Conclusions: Treatment  of  SFA  stent  thrombosis  should  be undertaken  with  the  understanding  of  the
underlying  thrombotic  causes  and the  knowledge  of  the  most  appropriate  therapeutic  options.  A  per-
cutaneous  mechanical  strategy  with  the  Angiojet  Ultra  Thrombectomy  System  may  achieve  rapid  and
complete  recanalization  even  in  the  presence  of  huge  thrombotic  burden.
<Learning objective:  New  devices  have  been  available  for huge  thrombotic  burden  management  in
acute  clinical  peripheral  settings.  A  few  clinical  experiences  have  been  described  and  the case  we  present
shows  the  safety  and  efﬁcacy  of the  rheolytic  thrombectomy  for femoral  stent  thrombosis  management
avoiding  bleeding  and  distal  embolization  risks.>
©  2014  Japanese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.ntroduction
Thrombotic occlusion of the superﬁcial femoral artery (SFA) is
till a major cause of limb ischemia and loss. Conventional treat-
ent includes thrombo-embolectomy with a Fogarty catheter or
urgical bypass, while loco-regional pharmacologic thrombolysis
s an alternative therapy [1]. However, thrombolysis is limited by
igh cost and a non-negligible risk of hemorrhagic complications.
ecently, percutaneous mechanical thrombectomy has been used
uccessfully.
We describe a case of SFA thrombotic occlusion early after
tenting in an aspirin low-responsive patient who was  successfully
reated with rheolytic thrombectomy.
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A  65-year-old man  who was  a heavy smoker was admitted for
intermittent claudication of the left inferior limb with a <50 m
symptom-free interval. Angiography showed chronic total occlu-
sion of the proximal left SFA [TransAtlantic Inter-Society Consensus
(TASC) D lesion, >15 cm in length, according to TASC II classiﬁca-
tion] (Fig. 1a). After antegrade approach, heparin (8000 U i.v.) was
administered in a bolus and after predilation, two overlapping niti-
nol self-expandable stents (Absolute Pro 60 mm + 40 mm × 8.0 mm;
Abbott Vascular, Abbott Park, IL, USA) were implanted in the
proximal SFA and two  nitinol self-expandable stents (Absolute
Pro 80 mm + 100 mm × 8.0 mm;  Abbott Vascular) in the distal SFA
with a good angiographic result. However, a severe no ﬂow-
limiting linear dissection of the mid  non-stented SFA segment was
observed and left untreated (Fig. 1b). The patient was discharged on
aspirin (100 mg/day) indeﬁnitely and clopidogrel (75 mg/day) for
two months. Ten days later, the patient was  urgently hospitalized
because of severe pain at rest of the left inferior limb with clinical
vier Ltd. All rights reserved.
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Fig. 1. (a) Baseline angiography showing chronic total occlusion of the left superﬁcial femoral artery (SFA). (b) Final result after recanalization and implantation of four
self-expandable nitinol stents. Note the residual linear dissection between the proximal and distal stented segments (arrow). (c) Multidetector computed tomography scan
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ierformed 10 days after stenting: longitudinal view of the superﬁcial femoral arter
tent  thrombosis. (e) Final angiographic result after emergency transcatheter rheoly
FA  patency with moderate in-stent hyperplasia (arrows).
igns of acute peripheral ischemia but no sensory loss (grade IIa,
utherford classiﬁcation).
Duplex  ultrasound showed proximal SFA occlusion and
ulti-detector computed tomography angiography demonstrated
hrombotic stent occlusion (Fig. 1c). At angiography, thrombotic
cclusion was conﬁrmed with minimal collateral ﬂow (Fig. 1d).
he occlusion was crossed with a 0.035 in. hydrophilic guidewire
Terumo, Tokyo, Japan); a low-proﬁle tip (2.0–1.2 mm)  Xpeedior
heolytic catheter (Medrad, Warrendale, PA, USA) was activated
or three 90-s cycles and advanced over the guide wire with to-
nd-fro movements into the occluded stents. Thrombus removal
nd recanalization were obtained without any distal emboliza-
ion. The mid  SFA dissected segment was treated with stenting
Absolute Pro 60 mm × 8.0 mm;  Abbott Vascular) (Fig. 1e). Platelet
eactivity tests were performed [2] and showed good response
o clopidogrel. Indeed, 48.6% platelet reactivity index was found
ith the vasodilator-stimulated phosphoprotein assay, 152 platelet
eactivity units was measured with the VerifyNow P2Y12 test (Acc-
metrics Inc., San Diego, CA, USA), and 44% of maximal aggregation
ith ADP-induced platelet-rich plasma aggregation. On the con-
rary, a low response to aspirin was observed with the VerifyNow
spirin test (Accumetrics) (515 aspirin reactivity unit) and the
rachidonic acid- and collagen-induced platelet-rich plasma aggre-
ation (75% and 80% of maximal aggregation, respectively) (Fig. 2).
spirin dose was increased to 160 mg/day achieving better platelet
esponsiveness at 48 h as demonstrated by VerifyNow Aspirin test
286 aspirin reactivity unit) and arachidonic acid- and collagen-
nduced platelet-rich plasma aggregation (3% and 41% of maximaling occlusive thrombosis. (d) Selective angiography of the SFA conﬁrming diffuse
rombectomy and stenting (arrows). (f) Six-month angiographic follow-up showing
aggregation,  respectively). The patient was  discharged on aspirin
160 mg/day and clopidogrel 75 mg/day. At the 6-month follow-
up, he was  asymptomatic and control angiography showed stent
patency with moderate in-stent hyperplasia (Fig. 1f).
Discussion
SFA  stenting compares favorably to balloon angioplasty, particu-
larly in long lesions. Although early thrombosis of peripheral nitinol
stents is uncommon, it may  cause a serious clinical challenge pre-
senting with acute and severe limb ischemia that requires emergent
intervention. One of the major reasons lies in an incomplete vessel
revascularization with in-ﬂow or out-ﬂow disease left untreated
and precipitating a thrombotic milieu. Late SFA stent thrombo-
sis has also been described, often associated with stent fracture.
Indeed, the superﬁcial course of the SFA with crossing of ﬂexion
points as well as interaction with the surrounding musculature
potentially exposes the artery to relevant external forces, including
compression, torsion, and elongation that may  cause stent frac-
ture. This may  have a negative impact on vessel patency late after
stenting [3].
Acute  limb ischemia is a serious condition that has been associ-
ated with a risk of limb-loss ranging from 5% to 30%, and a mortality
rate ranging from 11% to 18% [4–6]. Patients with acute limb
ischemia usually present with minimal or no sensory loss, which,
in the absence of paralysis is deﬁned as grade IIa or, in the presence
of sensory loss extending beyond the toes, grade IIb according to
Rutherford acute limb ischemia classiﬁcation [7,8]. In these cases,
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[ig. 2. Platelet aggregation induced by arachidonic acid (a) and collagen (b) determ
atient on two  aspirin dosages: 100 mg/day (blue line) and 160 mg/day (red line). A
hrombolysis is associated with slow ﬂow restoration, which may
ggravate tissue damage and cause hemorrhagic complications [9].
 common treatment option is surgical management employing a
hrombolectomy catheter or bypass surgery, especially for severe
cute limb ischemia when motor deﬁcit is present (Rutherford class
Ib–III). Recently, catheter-assisted thrombectomy has been associ-
ted with a lower mortality rate as compared to surgery in high-risk
atients [10,11]. In our case, it is likely that the major role in early
tent thrombosis was played by the severe, left untreated vessel
issection in-between the proximal and distal SFA stented seg-
ent. The intrinsic low-responsiveness of the patient to a standard
ose of aspirin (100 mg)  prompted a high platelet activation that,
ogether with the unfavorable anatomic setting, favored throm-
us formation and vessel closure. This situation was overcome by
ncreasing the daily aspirin dosage, as conﬁrmed by a signiﬁcantly
ower aspirin reactivity to VerifyNow test.
Indeed, the huge thrombotic burden occluding a long SFA seg-
ent was a serious condition and a therapeutic challenge requiring
rompt intervention in order to prevent limb loss. We obtained
apid thrombus removal and blood ﬂow restoration without distal
mbolization using the Xpeedior rheolytic catheter connected to
he Angiojet Ultra Thrombectomy System (Medrad). This device
llows high-speed saline jets inside the catheter that create a
owerful low-pressure zone that aspirates the thrombus into the
atheter and removes it from the vessel.
onclusions
In accordance with previous clinical experience from small case
eries [12,13], our case underlines the importance of understand-
ng the potential causes of occlusive thrombosis after SFA stenting
n order to offer to the patient the most appropriate and effec-
ive treatment. Thrombosis of a long SFA stented segment is a real
herapeutic challenge due to the huge thrombus burden. The Angio-
et Ultra Thrombectomy System seems a safe and effective tool to
chieve prompt recanalization in these cases avoiding the risk of
istal embolization.t 5 min  in a healthy subject not taking any antiplatelet drug (black line) and in our
pirin.
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